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Background: Atrial fibrillation (AF) is a common arrhymia, and it results in increased risk of thromboembolism and
decreased cardiac function. In patients undergoing cardiac surgery, concomitant radiofrequency ablation to treat AF
is effective in restoring sinus rhythm (SR). This study is an observational cohort study aimed to investigate the safety
and efficacy of bipolar radiofrequency ablation (BRFA) for treating AF combined with heart valve diseases.
Methods: Clinical data were analyzed retrospectively from 324 cases of rheumatic heart disease combined with
persistent AF patients who underwent valve replacement concomitant BRFA. The modified left atrial and the simplified
right atrial ablation were used for AF treatments. Of the 324 patients, 248 patients underwent mitral valve replacement
and 76 patients underwent double valve replacement. Meanwhile, 54 patients underwent concomitant thrombectomy
and 97 underwent tricuspid valvuloplasty. And all of them received temporary pacemaker implantation. The 24 hours
holter electrocardiogram (ECG) monitoring and echocardiography was performed before the operation, on the first day
after operation, on discharge day, and at 6 and 12 months after operation.
Results: There were 299 patients with SR on the first day after operation (92.30%), 12 patients with junctional rhythm
(3.70%), 11 patients with AF (3.39%), and 2 patients with atrial flutter (0.62%). The temporary pacemaker was used in
213 patients (65.74%) with heart rates less than 70 beat/minute in the ICU. Two patients died early and the mortality
rate was 0.62%. Two patients had left ventricular rupture and the occurrence rate was 0.62%. They both recovered.
There was no degree III atrioventricular blockage and no permanent pacemaker implantation. Overall survival rate
was 99.38% (322 cases) with SR conversion rate of 89.13% (287 cases) at discharge. The SR conversion rate was
87.54% and 87.01% at 6 and 12 months after operation. Sinus bradycardia occurred in 3.42% of patients at 6 months
after operation and in 3.03% of patients at 12 months after operation. Echocardiography showed that the left atrial
diameter was significantly decreased, and ejection fraction and fractional shortening were significantly improved.
Conclusions: BRFA for treating AF in concomitant valve replacement is safe and with good efficacy.
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Atrial fibrillation (AF) is a common cardiac arrhythmia,
and frequently complicates the course of heart valve disease
[1-3]. Many patients who receive mitral valve replacement
(MVR) have AF, and many other of them develop AF after
the surgery [2]. The efficacy of internal medicine therapy
and electric cardioversion is not satisfactory and thus* Correspondence: chenlin853@aliyun.com
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reproduction in any medium, provided the ortheir clinical application is limited [3]. With the increasing
application of electrophysiological mapping, radiofrequency
ablation in the treatment of cardiac arrhythmia is in rapid
progress. Radiofrequency ablation is the breakthrough for
the treatment of chronic AF. In patients undergoing cardiac
surgery, concomitant radiofrequency ablation to treat AF is
effective in restoring sinus rhythm (SR) [4-7].
Mccarthy et al. [8] applied 5 different methods for con-
current treatment of AF in 408 cases of heart operation.
They found that the cure rate for patients received
strong focused ultrasound ablation was only 43% in thetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Chen et al. BMC Surgery 2014, 14:32 Page 2 of 6
http://www.biomedcentral.com/1471-2482/14/32one-year follow up time. Cox-maze procedure is the
classic and effective surgical treatment for AF, with a
high success rate of 90%. On the contrary, traditional
cut-and-sew technique is time-consuming and difficult
with complex operation incision and high rate of post-
operative complications (nearly 23% of patients had
postoperative implantation of permanent pacemaker),
and thus its application is limited [9]. In addition, the
success rate for pulmonary vein ablation is 69%, while
the success rate for left atrial maze ablation and biatrial
maze ablation both are 79%, which indicates the significant
efficacy of atrial maze ablation.
In this study, the safety and efficacy of left atrial and
simplified right atrial maze ablation for the treatment
of persistent AF in concomitant valve replacement were




From September 2009 to June 2012, 3360 consecutive
patients underwent heart valve replacement for rheumatic
heart disease at Xinqiao Hospital, Third Military Medical
University, ChongQing, China. Of the 3360 patients, 324
patients underwent valve replacement and concurrent
BRFA for treatment of persistent AF. Among them, there
were 136 males and 188 females, aging from 28 to 71 years
old. They had clinical presentations like angina and
shortness of breath, with AF history for 1 year to 15 years.
According to 2011 ACCF/AHA/HRS and 2013 EACTS
Guidelines [10,11], they all had long-persistent AF. Pre-
operatively they were confirmed of persistent AF by 12
lead electrocardiogram (ECG) examination and 24 hour
holter ECG monitoring. There were 86 cases in NYHA
functional class I to II, 182 in class III, and 56 in class IV.
Echocardiography showed that the left atrial diameter
(LAd) was 39 to 85 mm, left ventricular diameter (LVd)
was 41 to 75 mm, and left ventricular ejection fraction
(LVEF) was 40% to 67%. For patients with heart rate less
than 60 beat/min, or with LAd more than 85 mm, or
received operation before, or with severe pericardial
adhesions, concomitant BRFA were not performed.
Prior written and informed consent were obtained
from every patient and the study was approved by the
ethics review board of Xinqiao Hospital, Third Military
Medical University.
Surgical approaches
Operations were performed under general anesthesia
with hypothermic cardiopulmonary bypass (CPB). Atricure™
BFRA apparatus was applied as the method described by
Sims et al. [1] and was adjusted according to the condition
of the patients. Briefly, the left and right pulmonary vein
(PVs) were carefully separated and encircled with a urinecatheter. With the guidance of the catheter, the bipolar
ablation clamp was positioned precisely around the PVs.
Circle ablation of the right and left PVs was performed
(see Figure 1). After Marsh ligaments cutting and cross-
clamp the ascending aorta, left atrial cavity was exposed
through a left atrial incision behind the interatrial groove.
Then the linear ablations were performed between the left
and right inferior PVs, between the left and right superior
PVs, and between the left superior PV and the opening
of left atrial appendage. The maze ablation was repeated
4-5 times during circle ablation of the right and left
PVs, during the linear ablation between the left and
right inferior PVs, and during the linear ablation between
the left and right superior PVs. Then, the orifice of left
atrial appendage was closed with continuous suture,
followed by valve replacement and the ablation of the
right atrium.
For patients with obviously enlarged left atrium, intera-
trial groove incision was performed for MVR. For patients
with severe tricuspid regurgitation, transseptal approach
was conducted for MVR. Aortic replacement procedure
(AVR) was performed through a incision of ascending
aorta. Both MVR and AVR were done in interrupted
suture in all the patients. After MVR, the ablation of
the right atrium was performed. The linear ablations
were performed in the regions from the vertical incision
on anterior wall of the right atrium to the interatrial
groove and to the tricuspid annulus; and, from the lower
edge of the incision to the coronary sinus ostium and to
the inferior vena cava; and, from the lower edge of the
coronary sinus ostium to the inferoseptal commissure.
Postoperative treatment and follow up
Holter ECG monitoring for 24 hours and echocardiog-
raphy were performed before the operation, on the first
day after operation, on discharge day, and at 6 months
and 12 months after operation. AF recurrence was defined
as the appearance of AF in the 24 hours holter ECG moni-
toring. During ICU, patients were treated with intravenous
amiodarone infusion. After they were transferred out of
ICU, they were treated with oral administration of 200 mg
amiodarone twice each day. When they were discharged,
oral administration of 200 mg amiodarone was given once
per day for 3-6 months.
Statistical analysis
SPSS V11.0 statistical software was applied for statistical
analysis. Data was presented as x ± s, and categorical
data was examined by X2 test. P < 0.05 was considered
significantly different.
Results
As shown in Table 1, among the 324 patients, 248 patients
underwent BRFA and concomitant MVR, and 76 patients
Figure 1 Radiofrequency ablation by a urine catheter-guided bipolar radiofrequency clamp technique. (A) Left and right pulmonary veins
were separated and circled with a urine catheter. (B) The bipolar radiofrequency clamp arm was inserted into the catheter. (C) The bipolar radiofrequency
clamp was directed by the catheter to go through the back wall of the left and right pulmonary veins. Then the circled ablation of the pulmonary veins
was performed. (D) Diagram of surgery shown in A. (E) Diagram of surgery shown in B. (F) Diagram of surgery shown in C.
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54 patients underwent concomitant thrombectomy,
and 97 patients underwent tricuspid valve annuloplasty
(including 33 cases using Cosgrove Edwards annuloplasty
ring). All patients received prophylactic temporary pace-
maker implantation. In ICU, when the heart rate was less
than 70 beat/minute, the temporary pacemaker was used.
A total of 299 patients had SR on the first day after
operation (92.30%), 12 patients had junctional rhythm
(3.70%), 11 patients had atrial fibrillation (3.39%), and 2
patients had atrial flutter (0.62%). In ICU, 213 patients
used temporary pacemaker (65.74%). Two patients died
early and the mortality rate was 0.62%. One of them died
the day after operation because of pulmonary hypertension
crisis, and the other died 29 days after the operation
because of multiple organ failure. There were 2 cases of
left ventricle rupture, with an occurrence rate of 0.62%.
One left ventricle rupture appeared 8 hours after trans-
ferred to ICU and the other left ventricle ruptureTable 1 General surgical information (x ± s)
Variable n (%) or x ± s
Gender (male/female, case) 136 (42.00)
Age (year) 50.67 ± 18.33
Mitral valve replacement (case) 248 (76.54)
Double valve replacement (case) 76 (23.46)
Concomitant tricuspid valve annuloplasty (case) 97 (29.94)
Concomitant thrombectomy (case) 54 (16.67)
Cardiopulmonary bypass time (min) 106.80 ± 25.72
Aortic occlusion time (min) 65.91 ± 20.01
Ventilation time (h) 20.70 ± 7.37
Chest tube drainage (ml) 358.11 ± 137.38appeared as soon as weaning off CPB. After treatment,
they were both recovered. Early operation complica-
tions and mortality rates were shown in Table 2. The
echocardiography changes before and after operation
were shown in Table 3. Echocardiography showed that
the left atrial diameter was significantly decreased, and
ejection fraction and fractional shortening were signifi-
cantly improved.
There was no degree III atrioventricular blockage.
Overall survival rate was 99.38% with SR conversion rate
of 89.13% at discharge. The SR conversion rate was
87.54% and 87.01% at 6 and 12 months of follow-up.
Sinus bradycardia, with heart beat ranging from 50-58
beat/minute, occurred in 3.42% of patients at 6 months
after operation and in 3.03% of patients at 12 months
after operation. They had no chief complaint, and there-
fore there were no permanent pacemaker implantation.
The ECG changes before and after operation were




Repeat thoracotomy 4 (1.23%)
Low cardiac output syndrome 9 (2.78%)
Respiratory failure 12 (3.70%)
Kidney failure 3 (0.93%)
Multiple organ failure 4 (1.23%)
Left atrium rupture 2 (0.62%)
Cerebral hemorrhage 1 (0.31%)
Early death 2 (0.62%)
Table 3 Echocardiography change before and after the operation (x ± s)
Groups Diameter of left artrium (mm) Ejection fraction (%) Fractional shortening (%)
Before operation (n = 324) 57.48 ± 15.16 56.57 ± 9.67 33.47 ± 7.08
Before discharge (n = 322) 38.81 ± 15.14## 59.30 ± 11.32 35.18 ± 6.67#
Six months after operation (n = 322) 36.94 ± 10.23## 62.35 ± 13.61# 34.53 ± 7.64
Twelve months after operation (n = 231) 37.66 ± 12.01## 64.01 ± 12.33# 35.73 ± 6.18#
Note: #compare with before operation; p < 0.05; ##p < 0.01.
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In this study, Atricure™ BRFA instrument was applied
for left atrial and simplified right atrial maze ablation
according to the method of Sims et al. [1] with minor
modifications. Compared with unipolar flushing type radio-
frequency ablation, Atricure™ BRFA instrument is with
simpler operation method and better atrial transmural
ablation. And, through using Atricure™ BRFA instrument, it
is easier to determine the transmural ablation time and
effect, and more effective to avoid the cardiac damage
[1,12-14]. The BRFA system is designed based on the stable
and good penetration properties of radiofrequency current.
The local hyperthermia effect induced by the radiofre-
quency current can produce tissue coagulation necrosis
and thus AF reentrant loop is blocked [1]. Schuessler et al.
[15] summarized the use of nine different unidirectional
devices (including four radiofrequency, two microwave,
two lasers and one cryothermic) for creating continuous
transmural lines of ablation from the atrial epicardium
in a porcine model. They defined a unidirectional device
as one in which all the energy was applied by a single
transducer on a single heart surface. The maximum pene-
tration of any device was 8.3 mm. All devices except one,
the AtriCure Isolator pen, failed to penetrate 2 mm in
some non-transmural sections. Melby et al. reported that
bipolar ablation of different atrial structures required
widely different amounts of energy and ablation times,
probably as the result of the inhomogeneity of atrial
geometry and tissue impedance [16]. In this study, the
ablation was repeated 4-5 times during circle ablation
of the right and left PVs, the linear ablation between
the left and right inferior and the linear ablation between
the left and right superior PVs. For performing the
procedure of maze ablation, extra 10 to 15 minutes
was required for cross-clamp and extra 20 to 35 minutes
for bypass. Our results were consistent with previousTable 4 Electrocardiogram change before and after the opera
Groups Sinus rhyme Junctional rhym
The day after operation (n = 324) 299 (92.30) 12 (3.70)
Before discharge (n = 322) 287 (89.13) 8 (2.48)
Six months (n = 322) 282 (87.58)* 7 (2.17)
Twelve months (n = 231) 201 (87.01)* 7 (3.03)
Note: *compare with the day after operation, p < 0.05.findings. Von Oppell et al. reported that an average of
30 minutes extra was required both for bypass and
cross-clamp when performing the procedure of maze
ablation [4]. The efficacy of BRFA in the present study
was satisfactory and 92.30% of patients had SR on the
first day after operation. Overall survival rate was
99.38% with SR conversion rate of 89.13% on discharge
day. The SR conversion rate was 87.54% at 6 months
after operation, and 87.01% at 12 months after operation.
Echocardiography showed that the left atrial diameter was
significantly decreased, and ejection fraction and fractional
shortening were significantly improved. The results were
very good, and it was similar to the reported guideline
[10]. Dunninga et al. [10] reported that BRFA, as an
adjunct to cardiac surgery, had a higher success rate in
restoring SR compared with no ablation for at least
1 year. Success rates ranged from 54% to 90% after a
medium-term follow-up for at least 12 months. There
is limited evidence suggesting superiority of BRFA
over unipolar energy as yet [10].
Since the occurrence rate of sinus bradycardia is higher
at early postoperative, all patients received prophylactic
temporary pacemaker implantation in this study. Sinus
bradycardia occurred in 91 patients (28.09%) during ICU.
Postoperative patients with sinus bradycardia usually
recovered around 3 days. During follow-up, sinus brady-
cardia rate was 3.42% at 6 months and 3.03% at 12 months
with heart rate of 50–60 beat/minutes, and there were no
complaints and no permanent pacemaker implantation.
In this study, the percentage of patients with early
postoperative respiratory failure was 3.7%, which was
relatively high. Increased lung injury may be caused by
the following reasons. During the BRFA procedure, there
was a short cross-clamp of the left and right superior PVs.
This may result in a sharp increase in pulmonary venous
pressure and cause injury to the pulmonary capillary andtion (%)
e Atrial fibrillation Atrial flutter Sinus bradycardia
11 (3.40) 2 (0.62) 91 (28.09)
17 (5.24) 10 (3.09) 9 (2.80)*
17 (5.27) 16 (4.97)* 11 (3.42)*
12 (5.19) 11 (4.76)* 7 (3.03)*
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during BRFA could lead to regional myocardial and PVs
injury, which may result in systemic inflammatory response
syndrome [1]. Thus, we suggest that ventilator support
should be properly prolonged after operation for patients
with long time left and right pulmonary vein isolation.
Rupture of left ventricle is one of the rare and most
serious complications of MVR. It is difficult to treat and
can cause high mortality rate [17]. There were 2 patients
of left ventricular rupture in this study. Both of them
were old female with severe mitral stenosis combined
with AF. This indicates that left ventricular rupture may
be one of the risks during performing MVR concomitant
BRFA in older women with AF and severe mitral stenosis.
We suppose that BRFA may injure the left ventricle
under mitral annulus by mistake during performing the
lineal ablation from interatrial groove incision margin
to posterior mitral valve annulus. And to perform MVR
concomitant BRFA for treating AF, the heart has to be
moved and lifted repeatedly. It might increase the pos-
sibility of atrioventricular dehiscence when the heart is
repeatedly moved and lifted during heart beating in old
female with severe stenosis of rheumatic mitral [17].
We suggest that during performing MVR concomitant
BRFA for AF, more attention should be paid to the
linear ablation from interatrial groove incision margin
to posterior mitral valve annulus. We recommend the
urine catheter guided BRFA clamp technique when
performing MVR concomitant BRFA. Compared with
the bipolar forceps, dissociative clamp has short operating
handle and appropriate radian. Dissociative clamp of the
appropriate size can be chosen according to the size of
heart. It is of great flexibility and is easy to control. With
dissociative clamp, the procedure is simplified and the
surgical trauma and risks are reduced during separating
the left and right pulmonary veins. Meanwhile, when
the left atrial is significantly enlarged and pulmonary
vein is widened, arm of bipolar radiofrequency forceps
might be too short to fully cover pulmonary vein. Traction
the urine catheter could support the bipolar radiofre-
quency clamp to completely cover the pulmonary vein.
When the catheter is removed, ablation pulmonary vein
could be more thorough. Ordinary catheter is convenient
to be obtained since materials are cheap. Catheter is
soft, smooth, and flexible, so the cardiac tissue will not
be injured.Conclusions
In conclusion, the efficacy of modified left atrial and simpli-
fied right atrial maze ablation by BRFA for the treatment of
AF is satisfactory. The procedure is a safe, feasible, effective
and simple surgical technique. However, its long-term
effects still need further study.Limitation
The present study is a retrospective and nonrandomized
study. Furthermore, follow-up duration is relatively short,
and a longer follow-up are required.
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